Cumberland Pharmaceuticals (CPIX) Income from Discontinued Operations (2019 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Income from Discontinued Operations of -$1.17 million for Q2 2026, compared with $2.26 million a year earlier.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Income from Discontinued Operations (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Discontinued Operations at Cumberland Pharmaceuticals was $1.09 million, down 51.7% year-over-year; for FY2021, it came in at $1.99 million, down 37.8% from FY2020.
- Annual Income from Discontinued Operations shows a three-year compound annual growth rate of -19.2% (FY2018 to FY2021).
- In prior years, Cumberland Pharmaceuticals' Income from Discontinued Operations was $3.21 million in FY2020 (-43.4%), $5.67 million in FY2019 (+49.8%) and $3.78 million in FY2018.
- The Q2 2026 figure stands as the lowest quarterly Income from Discontinued Operations in data going back to Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 8.00 Mn |
| 10 | Cumberland Pharmaceuticals | 110.73 Mn | 68.88 Mn | - | -1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Dec 31, 2021 | 503,318.00 |
| Sep 30, 2021 | 496,787.00 |
| Jun 30, 2021 | 498,807.00 |
| Mar 31, 2021 | 495,410.00 |
| Dec 31, 2020 | 872,064.00 |
| Sep 30, 2020 | 777,916.00 |
| Jun 30, 2020 | 738,622.00 |
| Mar 31, 2020 | 818,273.00 |
| Dec 31, 2019 | 2.40 Mn |
| Sep 30, 2019 | 1.35 Mn |
| Jun 30, 2019 | 771,709.00 |
| Mar 31, 2019 | 1.15 Mn |
API Access
Cumberland Pharmaceuticals Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=CPIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "CPIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=CPIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();